Rikke Søgaard

Rikke Søgaard is a Professor at the Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark (SDU), with strong affiliations to Odense University Hospital (OUH) and the Research Unit of Cardiac, Thoracic, and Vascular Surgery. Her work bridges clinical research and health policy, focusing on evidence-based healthcare prioritization and equity.

Her research interests center on Health Economics, Prevention and Screening, Health Inequality, and Cost-Effectiveness Analysis. She investigates disparities in access to care, pharmaceuticals, and surgical interventions, particularly in cardiovascular and metabolic diseases. Her work frequently employs cohort studies, randomized controlled trials, and health economic modeling to inform public health policy.

The trends in her recent publications reveal a consistent focus on population-level health interventions, including diabetes screening, cardiovascular prevention, and mental health service utilization. Her research often evaluates the real-world impact and cost-effectiveness of screening programs and therapeutic access, emphasizing equity across socioeconomic and geographic lines.

• Member of the Danish Medicines Council (Medicinrådet) since 2023

She actively contributes to national health policy discourse, as seen in her media appearances and advisory role in the Medicinrådet, where transparency and legitimacy in decision-making are emphasized. While specific grant details are not listed, her leadership in major trials like DANCAVAS and CAESAR indicates substantial research funding. She collaborates extensively with clinical researchers and public health experts across Denmark, contributing to a robust network in cardiovascular and public health research.

Rikke Søgaard is embedded in a multidisciplinary research environment at SDU and OUH, working closely with teams in cardiology, vascular surgery, epidemiology, and health services research. Her work supports evidence-based prioritization in the Danish healthcare system, particularly through economic evaluation of screening and treatment strategies.